Clinical Trial Update: Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing the clinical efficacy and safety of a novel epicutaneous allergen immunotherapy for grass pollen–induced rhinoconjunctivitis; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinoconjunctivitis

Snippet

Sponsor: University of Zurich | Conditions: Rhinoconjunctivitis | Phase 1 | Status: COMPLETED